Russian model treatment of pediatric Hematology-Oncology recognized as unique in the world

The world health organization (who) recognized the expertise of Russian children oncologists priority and requested that the model treat pediatric Hematology-Oncology in the CIS countries. In 2017 for the protocols modified by doctors from Russia, began to treat in many countries. This was announced by the head of the office of noncommunicable diseases the European office of the who, Joao Breda on February 13 at a press conference. The event is timed to the International day of children with cancer, celebrated on February 15.

The Director of the Institute of management and translational medicine SMRC dgoi them. Dmitry Rogachev Svetlana Varfolomeeva he explained: “the Russian model is the following: modern, standardized treatment with the use of hard modes of the Protocol, without introducing new medicinal agents and forms. The use of such models has led to the fact that in our country the survival rate of children with malignant tumors for the last 10 years has increased from 10% to 80%. This experience is unique to the whole world.”

Speaking in 2017 for the 70th Assembly of the who in Geneva, the Minister of health of the Russian Federation Veronika Skvortsova and CEO of the SMRC of pediatric Hematology, Oncology and immunology. Dmitry Rogachev, chief children’s hematologist of the Ministry of health of Russia, academician of the RAS Alexander Rumyantsev reported to colleagues how it was possible to achieve this. “The creation of the first Russian multicenter study for the treatment of lymphoblastic leukemia was allowed to do what we always say: children should be treated equally, they should be fully available therapy. This was done, and on the basis of this explosion – not because they used new drugs, but because it was properly optimized therapy. This experience as unique. In all countries the results were decades,” said Svetlana Varfolomeeva.